Innovator’s Corner

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 3366.

Product Description

Paul Laikind, PH.D., President and CEO of ViaCyte, talks about the company’s research on a stem-cell derived therapy for diabetes.

FEEDBACK